Aditxt, Inc. Increase (Decrease) in Inventories
Aditxt, Inc. (ADTX) reported Increase (Decrease) in Inventories of -$9.29 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-05-20
- Aditxt, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$9.29K.
- Aditxt, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$798.00.
- Aditxt, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$1.04K.
- Aditxt, Inc. increase (decrease) in inventories for the quarter ending 2025-06-30 was -$1.44K.
- Aditxt, Inc. increase (decrease) in inventories for fiscal 2025 was -$5.47K.
- Aditxt, Inc. increase (decrease) in inventories for fiscal 2024 was -$734.26K.
- Aditxt, Inc. increase (decrease) in inventories for fiscal 2023 was -$204.59K, a 144.93% decline from fiscal 2022.
- Aditxt, Inc. increase (decrease) in inventories for fiscal 2022 was $455.40K, a 7.94% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$9.29K 10-Q · filed 2026-05-20 | -$10.09K derived: sum of 2 quarters · filed 2026-05-20 | -$11.13K derived: sum of 3 quarters · filed 2026-05-20 | -$12.57K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-12-31 | -$798.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$1.84K derived: sum of 2 quarters · filed 2026-03-31 | -$3.28K derived: sum of 3 quarters · filed 2026-03-31 | -$5.47K 10-K · filed 2026-03-31 |
| 2025-09-30 | -$1.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | -$2.48K derived: sum of 2 quarters · filed 2025-11-18 | -$4.67K 10-Q · filed 2025-11-18 | -$82.42K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-06-30 | -$1.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$3.63K 10-Q · filed 2025-08-14 | -$81.38K derived: sum of 3 quarters · filed 2026-05-20 | -$557.88K derived: sum of 4 quarters · filed 2026-05-20 |
| 2025-03-31 | -$2.19K 10-Q · filed 2026-05-20 | -$79.94K derived: sum of 2 quarters · filed 2026-05-20 | -$556.44K derived: sum of 3 quarters · filed 2026-05-20 | -$613.71K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | -$77.75K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$554.26K derived: sum of 2 quarters · filed 2026-03-31 | -$611.52K derived: sum of 3 quarters · filed 2026-03-31 | -$734.26K 10-K · filed 2026-03-31 |
| 2024-09-30 | -$476.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-18 | -$533.77K derived: sum of 2 quarters · filed 2025-11-18 | -$656.51K 10-Q · filed 2025-11-18 | -$769.11K derived: sum of 4 quarters · filed 2025-11-18 |
| 2024-06-30 | -$57.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$180.00K 10-Q · filed 2025-08-14 | -$292.61K derived: sum of 3 quarters · filed 2025-08-14 | -$452.99K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$122.73K 10-Q · filed 2025-05-15 | -$235.34K derived: sum of 2 quarters · filed 2025-05-15 | -$395.73K derived: sum of 3 quarters · filed 2025-05-15 | -$140.76K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$112.60K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$272.99K derived: sum of 2 quarters · filed 2025-03-31 | -$18.03K derived: sum of 3 quarters · filed 2025-03-31 | -$204.59K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$160.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-18 | $94.58K derived: sum of 2 quarters · filed 2024-11-18 | -$91.99K 10-Q · filed 2024-11-18 | -$584.32K derived: sum of 4 quarters · filed 2024-11-18 |
| 2023-06-30 | $254.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $68.40K 10-Q · filed 2024-08-19 | -$423.93K derived: sum of 3 quarters · filed 2024-08-19 | -$314.40K derived: sum of 4 quarters · filed 2024-08-19 |
| 2023-03-31 | -$186.56K 10-Q · filed 2024-05-20 | -$678.90K derived: sum of 2 quarters · filed 2024-05-20 | -$569.37K derived: sum of 3 quarters · filed 2024-05-20 | -$278.43K derived: sum of 4 quarters · filed 2024-05-20 |
| 2022-12-31 | -$492.33K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$382.80K derived: sum of 2 quarters · filed 2024-04-16 | -$91.86K derived: sum of 3 quarters · filed 2024-04-16 | $455.40K 10-K · filed 2024-04-16 |
| 2022-09-30 | $109.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $400.47K derived: sum of 2 quarters · filed 2023-11-14 | $947.73K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $290.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $838.20K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $547.26K 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | $494.70K 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |